首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR INHIBITING ACTIVITY AND/OR EXPRESSION OF MATRIX METALLOPROTEINASE, INHIBITING PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE, AND/OR PROMOTING EXPRESSION OF COLLAGEN, AND USE THEREOF

PHARMACEUTICAL COMPOSITION FOR INHIBITING ACTIVITY AND/OR EXPRESSION OF MATRIX METALLOPROTEINASE, INHIBITING PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE, AND/OR PROMOTING EXPRESSION OF COLLAGEN, AND USE THEREOF

机译:用于抑制基质金属蛋白酶的活性和/或表达,抑制经丝裂原活化的蛋白激酶的磷酸化和/或促进胶原蛋白表达的药物组合物及其用途

摘要

PROBLEM TO BE SOLVED: To provide improvement and/or care of skin quality by inhibiting activation and/or expression of matrix metalloproteinase (MMP), inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK), and/or promoting expression of collagen.SOLUTION: A compound of formula (I), a pharmaceutically acceptable salt and an ester of the compound, and a mixture of them are used.
机译:要解决的问题:通过抑制基质金属蛋白酶(MMP)的激活和/或表达,抑制有丝分裂原激活的蛋白激酶(MAPK)的磷酸化和/或促进胶原蛋白的表达来改善和/或护理皮肤质量。溶液:使用式(I)的化合物,该化合物的可药用盐和酯,以及它们的混合物。

著录项

  • 公开/公告号JP2012056937A

    专利类型

  • 公开/公告日2012-03-22

    原文格式PDF

  • 申请/专利权人 CHINA MEDICAL UNIV;

    申请/专利号JP20110119563

  • 申请日2011-05-27

  • 分类号A61K31/19;C07J63;A61P43;A61P17/16;A61K8/63;A61Q19;A61Q19/08;

  • 国家 JP

  • 入库时间 2022-08-21 17:41:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号